Human Interferon alpha/beta receptor 2 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Human Interferon alpha/beta receptor 2 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHuman Interferon alpha/beta receptor 2
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatantigen affinity purified
Size0.05 mL, 0.1 mL
Concentrationn/a
ApplicationsELISA (EIA), Immunohistochemistry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAssociates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity.
ImmunogenImmunogen: Recombinant human Interferon alpha/beta receptor 2 protein(27-243aa) Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-83256 / sc-83257 / sc-83258 / sc-704 / sc-30014
Other Names[Interferon alpha/beta receptor 2; IFN-R-2; IFN-alpha binding protein; IFN-alpha/beta receptor 2; Interferon alpha binding protein; Type I interferon receptor 2; IFNAR2; IFNABR; IFNARB], [IFNAR2; IFNAR2; IFN-R; IFNABR; IFNARB; IFN-alpha-REC; IFNABR; IFNARB; IFN-R-2; IFN-alpha binding protein; IFN-alpha/beta receptor 2]
Gene, Accession #[IFNAR2], Gene ID: 3455, NCBI: NP_000865.2, UniProt: P48551
Catalog #MBS1494519
Price$120, $160
Order / More InfoHuman Interferon alpha/beta receptor 2 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.